NSE · AI Signal & Stock Analysis · Bearish
As of Sep 28 2026, 6:47 PM, AkshayaAI's signal for SENORES is Bearish ↓ (moderate move); technical trend raise-2026-09-07; trading at ₹1,497.50 (+4.84% today); neutral (RSI 58).
Data as of Sep 28 2026, 6:47 PM. Informational analytics only — not investment advice.
| AI signal | Bearish ↓ · Moderate move |
|---|---|
| Technical trend | RAISE-2026-09-07 |
| Price | ₹1,497.50 |
| Change today | +4.84% |
| RSI (14) | 57.80 |
| Relative volume | 1.05 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | ₹6,226 Cr |
| P/E | 47.73 |
| Cap category | Mid Cap |
| 52-week high | -3.4% away |
| 52-week low | +122.3% above |
| Delivery volume | — |
| Sector | Drug Manufacturers - General |
As of Sep 28 2026, 6:47 PM, AkshayaAI's signal for SENORES (Senores Pharmaceuticals Limited) is Bearish with a moderate move, and its technical trend is raise-2026-09-07. The composite score and full factor breakdown are available to signed-in members.
SENORES's RSI is neutral (RSI 58). A reading above 70 is typically overbought and below 30 oversold.
SENORES is trading about 3% below its 52-week high and 122% above its 52-week low as of Sep 28 2026, 6:47 PM.
SENORES's market capitalisation is ₹6,226 Cr as of Sep 28 2026, 6:47 PM.
SENORES is classified under Drug Manufacturers - General in AkshayaAI's taxonomy.
AkshayaAI refreshes its signals daily. The figures on this page are timestamped as of the latest run shown above.
No. AkshayaAI provides informational, AI-generated analytics for SENORES — not personalised investment advice. Always do your own research.
GLAXO · MARKSANS · PFIZER · RUBICON · SANOFI · SANOFICONR
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Sep 28 2026, 6:47 PM and may not reflect real-time prices. Always do your own research. How these signals work →
Instant, data-backed answers — free to try.